Day: May 21, 2020

TORONTO, May 21, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) has issued an additional $2 million worth of unsecured convertible debentures (collectively, the “Second Tranche”) under its $25 million unsecured convertible debenture standby facility with an institutional investor (the “Investor”) as previously announced on April 28, 2020 (the “Original Offering”).Under the Second Tranche, the convertible debentures issued to the Investor have a conversion price of $0.425 per common share of the Company (each a “Common Share”), and the Investor received warrants to purchase 2,588,235 Common Shares until May 21, 2022 at an exercise price of $0.51 per Common Share. Each convertible debenture will mature on May 21, 2022 and will bear guaranteed interest from the date of issue...

Fiscal Fourth Quarter and Other Recent Highlights:Net investment income per share for the quarter was $0.59 compared to $0.54 for the quarter ended December 31, 2019Net asset value per share as of the end of the quarter was $15.70 compared to $18.27 as of December 31, 2019, a 14.1% decrease driven by the disruption in the global economy which has resulted from the COVID-19 pandemic and which has negatively impacted the fair value of the Company’s investment portfolioNew investment commitments made during the quarter totaled $153 million (1)Gross fundings during the quarter totaled $210 million (2)Net fundings during the quarter totaled $8 million, including $47 million for revolversNet leverage (3) as of the end of the quarter was 1.71x, compared to 1.43x as of December 31, 2019Received 97% of contractual interest payments during the...

DUBLIN, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Giga-tronics Incorporated (OTCQB:GIGA) will release results for the fourth quarter and the fiscal year ended March 28, 2020 on Thursday May 28, 2020 after the close of trading on the OTCQB Market.Also on May 28, 2020, Giga-tronics will host a conference call at 4:30 p.m. ET to discuss the results and provide an update on Company operations.To participate in the call, dial: (888) 517-2470 or (630) 827-6818 and enter PIN Code 6379613#.  It is recommended that you call in five to ten minutes prior to the start time. You may also listen to the call via the Giga-tronics website at www.gigatronics.com.A replay of the call will be available later on the Giga-tronics website under “Investor Relations”.  This conference call will reflect management views as of May 28, 2020 only.Giga-tronics...

PHILADELPHIA and BELGRADE, Serbia, May 21, 2020 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), the global leader in managing construction risk, announced today that it has signed a contract extending the budget of its ongoing assignment providing technical assistance services to the European Investment Bank (EIB) for the implementation of the Infrastructure Project Facility 7 (IPF7) in the Western Balkans.In 2018, Hill began leading a consortium of international companies in the implementation of the IPF7, financed by the European Commission / Directorate-General for Neighbourhood and Enlargement Negotiations. With a current budget of over €34.5 million, the project provides a much-needed mechanism to facilitate the realization of bankable infrastructure investments in the energy, environmental, social, and transportation sectors...

JSC “Latvijas Gāze” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on May 28, 2020 at 16:00 (EEST). To join the webinar please follow the instructions below.Webinar will be hosted by Sebastian Groeblinghoff, Vice-Chairman of the Management Board of JSC “Latvijas Gāze”, and will be held in English.During the webinar Sebastian Groeblinghoff will analyze “Latvijas Gāze” Group’s unaudited financial results of 3 months 2020 (to be published on May 27, 2020) and inform about other key initiatives of the Group. After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance until May 27 to e-mail: ieva.unda@nasdaq.com.  What is webinar?Webinar is a virtual conference, during which company’s...

AS „Latvijas Gāze” aicina piedalīties uzņēmuma rīkotajā virtuālajā konferencē (vebinārā) 28. maijā plkst. 16:00 (pēc Latvijas laika). Lai piedalītos vebinārā, tam ir iepriekš jāreģistrējas – detalizēta informācija sniegta zemāk.Virtuālo konferenci (vebināru) vadīs un uz dalībnieku jautājumiem atbildēs AS „Latvijas Gāze” valdes priekšsēdētāja vietnieks Sebastians Grēblinghofs. Vebināra prezentācija notiks angļu valodā, taču būs iespēja uzdot jautājumus arī latviešu valodā.Vebināra ietvaros Sebastians Grēblinghofs analizēs AS “Latvijas Gāze” koncerna 2020. gada 3 mēnešu neauditētos finanšu rezultātus, kas tiks publicēti š.g. 27. maijā, kā arī informēs par aktualitātēm koncernā. Pēc prezentācijas uzņēmuma pārstāvis atbildēs uz vebināra dalībnieku jautājumiem.Ņemot vērā, ka vebināram atvēlētais laiks ir ierobežots, lūdzam Jūsu jautājumus...

NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced the approval by the Australian Human Research Ethics Committee to initiate the First-in-Human (FIH) clinical study of ANAVEX®3-71 (AF710B), an orally-administered small molecule targeting sigma-1 and M1 muscarinic receptors that is designed to be beneficial for neurodegenerative diseases.This represents Anavex’s 2nd novel clinical sigma-1 and muscarinic receptor program parallel to ANAVEX®2-73 (blarcamesine). Anavex is developing ANAVEX®3-71...

CAMBRIDGE, Mass., May 21, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced multiple presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform. AAN’s annual meeting was cancelled due to COVID-19 and the virtual platform allows for all accepted oral and poster presentations to be presented. The materials linked below will be available for approximately 10 months. “We are pleased by the breadth of losmapimod data selected for presentation, which highlights the progress we’ve made to develop a treatment for patients with facioscapulohumeral muscular dystrophy (FSHD) and our approach to treating the root cause of genetically defined rare...

LONDON, Ontario, May 21, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that it has secured distribution rights to ship its premium cannabis products to New Brunswick and Manitoba. These two new agreements extend Indiva’s distribution network to eight provinces. Indiva’s first shipments to Manitoba include INDIVA™ pre-rolls and THC capsules, and Bhang® Chocolate. Indiva expects that INDIVA™ and Bhang® products will be available in Manitoba stores within the next two weeks. New Brunswick recently received Bhang® Chocolate, which is now available for purchase at www.cannabis-nb.com.“We are proud to continue to grow our distribution network across Canada,” Niel Marotta, Indiva’s President and Chief Executive Officer, said. “As of today, we are nearly a nationwide...